Journal Menu► ▼ Journal Menu
Journal Browser► ▼ Journal Browser
Special Issue "Cancer Vaccines"
A special issue of Vaccines (ISSN 2076-393X).
Deadline for manuscript submissions: closed (31 March 2015) | Viewed by 77398
Special Issue Editor
Special Issue Information
The past few years have demonstrated great progress in the field of tumor immunotherapy through agents that address mechanisms of immune escape. Many of today’s immune based therapies depend on augmenting pre-existing immunity in cancer patients. For this reason there is increasing interest in the further development of cancer vaccines. The advent of the last decade has allowed the identification of multiple new antigens, new technologies, and new clinical settings in which to test vaccines.
The journal Vaccines would like to publish a special issue on Cancer Vaccines. This issue will bring together preliminary data and up-to-date breakthroughs in the discipline that now reflect our understanding of how best cancer vaccines can and should be employed. As a well-known expert in the field, we hope that you will agree to be a contributor to the issue.
I look forward to working with you to deliver a state of the art edition that will serve as a roadmap for the field.
Prof. Mary Lenora (Nora) Disis
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Vaccines is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2200 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
- cancer vaccines
- tumor antigens
- peptide vaccines
- DNA vaccines
- dendritic cell vaccines